CA2112366A1 - Methode et appareil de traitement des tissus - Google Patents
Methode et appareil de traitement des tissusInfo
- Publication number
- CA2112366A1 CA2112366A1 CA002112366A CA2112366A CA2112366A1 CA 2112366 A1 CA2112366 A1 CA 2112366A1 CA 002112366 A CA002112366 A CA 002112366A CA 2112366 A CA2112366 A CA 2112366A CA 2112366 A1 CA2112366 A1 CA 2112366A1
- Authority
- CA
- Canada
- Prior art keywords
- electrode device
- electrode
- tissue
- treated
- area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 229940079593 drug Drugs 0.000 claims abstract description 48
- 239000003814 drug Substances 0.000 claims abstract description 48
- 230000005684 electric field Effects 0.000 claims abstract description 21
- 230000000699 topical effect Effects 0.000 claims abstract description 15
- 230000003779 hair growth Effects 0.000 claims description 10
- 239000000976 ink Substances 0.000 claims description 6
- 230000000638 stimulation Effects 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 37
- 210000001519 tissue Anatomy 0.000 description 23
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 12
- 229940107889 rogaine Drugs 0.000 description 11
- 210000004761 scalp Anatomy 0.000 description 10
- 238000012377 drug delivery Methods 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000003128 head Anatomy 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001652 frontal lobe Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000012811 non-conductive material Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000037317 transdermal delivery Effects 0.000 description 2
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 102000001690 Factor VIII Human genes 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960000301 factor viii Drugs 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229940124641 pain reliever Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 229940100613 topical solution Drugs 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229940056345 tums Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72527991A | 1991-07-03 | 1991-07-03 | |
| US725,279 | 1991-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2112366A1 true CA2112366A1 (fr) | 1993-01-21 |
Family
ID=24913891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002112366A Abandoned CA2112366A1 (fr) | 1991-07-03 | 1992-07-02 | Methode et appareil de traitement des tissus |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0600914A4 (fr) |
| JP (1) | JPH06508783A (fr) |
| AU (1) | AU2336992A (fr) |
| CA (1) | CA2112366A1 (fr) |
| IL (1) | IL102406A0 (fr) |
| WO (1) | WO1993000959A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7643874B2 (en) | 2001-10-24 | 2010-01-05 | Power Paper Ltd. | Dermal patch |
| JP2003210591A (ja) * | 2002-01-24 | 2003-07-29 | Hisamitsu Pharmaceut Co Inc | エレクトロポレーション用経皮経粘膜適用製剤 |
| US7479133B2 (en) | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating acne and rosacea with galvanic generated electricity |
| US7477938B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Cosumer Companies, Inc. | Device for delivery of active agents to barrier membranes |
| US7477940B2 (en) | 2003-06-30 | 2009-01-13 | J&J Consumer Companies, Inc. | Methods of administering an active agent to a human barrier membrane with galvanic generated electricity |
| US7486989B2 (en) | 2003-06-30 | 2009-02-03 | Johnson & Johnson Consumer Companies, Inc. | Device for delivery of oxidizing agents to barrier membranes |
| US7477941B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of exfoliating the skin with electricity |
| US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
| US7507228B2 (en) | 2003-06-30 | 2009-03-24 | Johnson & Johnson Consumer Companies, Inc. | Device containing a light emitting diode for treatment of barrier membranes |
| US7480530B2 (en) | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Device for treatment of barrier membranes |
| US7476222B2 (en) | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of reducing the appearance of pigmentation with galvanic generated electricity |
| WO2010088914A1 (fr) * | 2009-02-05 | 2010-08-12 | Aalborg Universitet | Dispositif de régulation du débit sanguin sous-cutané |
| US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
| US11110272B2 (en) | 2011-12-08 | 2021-09-07 | Pilogics L.P. | Apparatus for stimulating hair growth and/or preventing hair loss |
| US9566431B2 (en) | 2014-04-07 | 2017-02-14 | Pilogics L.P. | Method of forming a large number of metal-ion-deposition islands on the scalp by a rapid series of brief electrode-contact events |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2322615A1 (fr) * | 1975-09-02 | 1977-04-01 | Le Goaster Jacqueline | Procede d'application cutanee en vue d'une penetration sous-cutanee de divers produits et produit pour sa mise en oeuvre |
| US4164226A (en) * | 1976-08-25 | 1979-08-14 | Robert Tapper | Iontophoretic burn-protection electrode structure |
| GB2132892B (en) * | 1983-01-10 | 1986-10-08 | Hayashibara Ken | Device for stimulating growth and regeneration of hair |
| US4736752A (en) * | 1986-11-28 | 1988-04-12 | Axelgaard Manufacturing Co., Ltd. | Transcutaneous medical electrode |
| DE3736072A1 (de) * | 1987-09-24 | 1989-04-13 | Soft Electrics & Cosmetics Ver | Verfahren und geraet zur foerderung des wohlbefindens des menschen und zur kosmetischen behandlung der haut |
| IL86076A (en) * | 1988-04-14 | 1992-12-01 | Inventor S Funding Corp Ltd | Transdermal drug delivery device |
| EP0419473A1 (fr) * | 1988-11-28 | 1991-04-03 | Innofinance Altalanos Innovacios Penzintetet | Appareil d'iontophorese |
-
1992
- 1992-07-02 CA CA002112366A patent/CA2112366A1/fr not_active Abandoned
- 1992-07-02 AU AU23369/92A patent/AU2336992A/en not_active Abandoned
- 1992-07-02 EP EP9292915713A patent/EP0600914A4/fr not_active Withdrawn
- 1992-07-02 JP JP5502332A patent/JPH06508783A/ja active Pending
- 1992-07-02 WO PCT/US1992/005587 patent/WO1993000959A1/fr not_active Ceased
- 1992-07-03 IL IL102406A patent/IL102406A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993000959A1 (fr) | 1993-01-21 |
| EP0600914A4 (fr) | 1994-11-02 |
| IL102406A0 (en) | 1993-01-14 |
| JPH06508783A (ja) | 1994-10-06 |
| EP0600914A1 (fr) | 1994-06-15 |
| AU2336992A (en) | 1993-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6078842A (en) | Electrode and iontophoretic device and method | |
| US6895271B2 (en) | Iontophoretic drug delivery electrodes and method | |
| US8560075B2 (en) | Apparatus and method for the treatment of headache | |
| US5450845A (en) | Medical electrode system | |
| US5540669A (en) | Iontophoretic drug delivery system and method for using same | |
| CA2112366A1 (fr) | Methode et appareil de traitement des tissus | |
| US8449522B2 (en) | Method and apparatus for providing topical anesthesia prior to and during a cosmetic procedure | |
| US10850094B2 (en) | DC output apparatus which can be used for therapeutic purposes | |
| US20100030129A1 (en) | Dermal patch | |
| JP2010075710A (ja) | 経皮パッチ | |
| US20070016125A1 (en) | Painless electroporating apparatus | |
| JP2000300682A (ja) | イオントフォレーシス用デバイス | |
| US20070016277A1 (en) | Lip augmentation device | |
| WO1995009032A1 (fr) | Dispositif d'administration de medicaments par iontophorese et son procede | |
| KR200403033Y1 (ko) | 피부팩용 휴대형 피부미용기기 | |
| TW401309B (en) | Improved electrode and iontophoretic device and method | |
| CA2343893C (fr) | Electrodes pour administration de medicaments par ionophorese | |
| KR20090090057A (ko) | 갈바닉 이온도입 기능을 갖는 화장품용기 | |
| KR20230091270A (ko) | 미세전류를 활용해 피부세포를 자극함으로써 안티에이징 효과를 극대화한 콜라겐 생성 휴대용 미용기기 | |
| CA2561340A1 (fr) | Systeme de perfusion a assistance electrique pour l'administration d'ingredients actifs ionises | |
| JPS62114567A (ja) | 生薬を使用した電気的刺激治療装置 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |